Related Experiment Video
Updated: Oct 25, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Inhibition of Rev-erbα ameliorates muscular dystrophy
Xuekai Xiong1, Hongbo Gao1, Yayu Lin1
1Department of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Abstract:
Duchene muscular dystrophy leads to progressive muscle structural and functional decline due to chronic degenerative-regenerative cycles. Enhancing the regenerative capacity of dystrophic muscle provides potential therapeutic options. We previously demonstrated that the circadian clock repressor Rev-erbα inhibited myogenesis and Rev-erbα ablation enhanced muscle regeneration. Here we show that Rev-erbα deficiency in the dystrophin-deficient mdx mice promotes regenerative myogenic response to ameliorate muscle damage. Loss of Rev-erbα in mdx mice improved dystrophic pathology and muscle wasting. Rev-erbα-deficient dystrophic muscle exhibit augmented myogenic response, enhanced neo-myofiber formation and attenuated inflammatory response. In mdx myoblasts devoid of Rev-erbα, myogenic differentiation was augmented together with up-regulation of Wnt signaling and proliferative pathways, suggesting that loss of Rev-erbα inhibition of these processes contributed to the improvement in regenerative myogenesis. Collectively, our findings revealed that the loss of Rev-erbα function protects dystrophic muscle from injury by promoting myogenic repair, and inhibition of its activity may have therapeutic utilities for muscular dystrophy.
Insights
Loss of Rev-erbα enhances muscle regeneration in Duchenne muscular dystrophy models by promoting myogenic repair and reducing inflammation. This suggests Rev-erbα inhibition as a potential therapy for muscular dystrophy.
Area of Science:
- Muscle Biology
- Regenerative Medicine
- Circadian Biology
Background:
- Duchenne muscular dystrophy causes progressive muscle degeneration.
- Enhancing muscle regeneration is a therapeutic strategy.
- The circadian clock protein Rev-erbα was previously shown to inhibit myogenesis.
Purpose of the Study:
- To investigate the role of Rev-erbα deficiency in dystrophin-deficient mdx mice.
- To determine if Rev-erbα loss ameliorates muscular dystrophy pathology.
Main Methods:
- Utilized dystrophin-deficient mdx mice lacking Rev-erbα.
- Assessed muscle pathology, regenerative response, and inflammatory markers.
- Analyzed myoblast differentiation and associated signaling pathways.
Main Results:
- Rev-erbα deficiency improved dystrophic pathology and reduced muscle wasting in mdx mice.
- Augmented myogenic response, enhanced neo-myofiber formation, and attenuated inflammation were observed.
- Loss of Rev-erbα in mdx myoblasts increased differentiation via Wnt signaling and proliferative pathways.
Conclusions:
- Rev-erbα deficiency protects dystrophic muscle by promoting myogenic repair.
- Inhibiting Rev-erbα activity shows therapeutic potential for muscular dystrophy.
- Targeting the circadian clock offers a novel approach for treating muscle degenerative diseases.
More Related Videos
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Skeletal Muscle Relaxants: Therapeutic Uses